Mercer Global Advisors Inc Sorrento Therapeutics, Inc. Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$1.57 - $4.76 $27,815 - $84,332	-17,717 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.45 - $4.17 $1,070 - $3,077	738 Added 4.35%	17,717 $60,000
Q3 2019 Nov 12, 2019	SELL	$2.05 - $2.69 $2,716 - $3,564	-1,325 Reduced 7.24%	16,979 $36,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $6,007 - $9,855	2,250 Added 14.02%	18,304 $49,000
Q1 2019 Apr 23, 2019	BUY	$1.86 - $5.94 $6,389 - $20,403	3,435 Added 27.22%	16,054 $76,000
Q1 2019 Apr 12, 2019	BUY	$1.86 - $5.94 $23,471 - $74,956	12,619 New	12,619 $30,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.